Nestlé to acquire supplements and honey brands in NZ


Friday, 01 July, 2022

Nestlé to acquire supplements and honey brands in NZ

Nestlé Health Science has agreed to acquire The Better Health Company (TBHC) in its entirety, including its supplement brand, GO Healthy, and Manuka honey brand, Egmont, as well as its manufacturing facility based in Auckland. The New Zealand Health Manufacturing facility for vitamins minerals and supplements will allow Nestlé Health Science to develop new products with regional considerations in mind.

Nestlé Health Science’s Head of Oceania, Asia, Middle East & Africa region Paul Bruhn said that the acquisition is a strategic fit for Nestlé Health Science.

“GO Healthy and Egmont are trusted brands with a track record of strong growth which complement our global portfolio of active lifestyle and health & wellness nutrition brands very well. We also see the opportunity to accelerate growth in the region through the manufacturing facility in Auckland, which will enable us to bring new products to local markets faster.”

Nestlé New Zealand CEO Jennifer Chappell said that the acquisition would strengthen Nestlé Health Science’s existing health and nutrition portfolio in New Zealand.

“This will strengthen our presence not just in New Zealand, but more broadly across the region, with the GO Healthy brand which is already present in Australia, China, Singapore, South Korea and Vietnam, and the globally known Egmont brand. This range of strong brands will take us well beyond our traditional food and beverage business and solidify our position in nutrition, health and wellness, while underscoring our commitment to New Zealand.”

The transaction to acquire TBHC is set to be finalised by the end of 2022. It is subject to regulatory approval and financial details are not being disclosed.

Image credit: ©stock.adobe.com/au/Liga Cerina

Related News

Expanding beyond biscuits: Arnott's acquires Prolife Foods

The Arnott's Group has expanded its 'better-for-you' snacking portfolio with the...

FDA investigates PFAS in seafood

The US Food and Drug Administration (FDA) expands its investigation on per- and polyfluoroalkyl...

Cell-cultured quail moving closer to Australians' plates

FSANZ is undertaking a second round of consultation on a proposed approach to allow cell-cultured...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd